WebMD News Brief

J&J Vaccinations Resume After FDA Gives Green Light

photo of vaccine

April 27, 2021 -- A number of states resumed giving people the Johnson & Johnson coronavirus vaccine on Saturday -- one day after the federal government cleared it for use again.

The Associated Press said Arizona, Colorado, Connecticut, Indiana, Louisiana, Maine, Massachusetts, Michigan, Missouri, Nevada, New York, Tennessee, Texas, and Virginia were among the states to give J&J vaccinations or order resumptions.

An Indiana mass vaccination site, the Indianapolis Motor Speedway, administered the J&J vaccine on Saturday. By early afternoon, 1,415 doses had been given.

“I can’t think of a better way to welcome the month of May in Indiana than getting your vaccine this week at the Yard of Bricks,” Chris Weaver, MD, chief clinical officer for Indiana University Health, told the AP.

The FDA and CDC had paused use of the J&J vaccine this month because of reports that a small number some people developed blood clots after being vaccinated.

Those agencies said Friday that use of the vaccine should resume in the United States for all adults, although health care providers should warn patients of the risk of developing the rare and serious blood clots. The FDA and CDC said potential benefits of the vaccine far outweighed its risks.

Public confidence in the J&J vaccine dropped after the FDA and CDC paused its use, according to a poll released Monday by ABC News and the Washington Post.

The poll of more than 1,000 U.S. adults was conducted April 18-21, before the pause was lifted.

About 73% of unvaccinated respondents said that they were unwilling to get the J&J vaccine, the poll said. About 41% said that it was very or somewhat unsafe.

About 46% of respondents said they thought the J&J vaccine was safe or somewhat safe, compared to 71% who said that about the Moderna vaccine and 73% who said that about the Pfizer vaccine.

WebMD Health News Brief


Associated Press: “With OK from experts, some states resume use of J&J vaccine”

The Washington Post: “The public’s concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds”

© 2021 WebMD, LLC. All rights reserved.